Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract.
about
NK cells in mucosal defense against infectionTissue instruction for migration and retention of TRM cellsA caprine herpesvirus 1 vaccine adjuvanted with MF59™ protects against vaginal infection and interferes with the establishment of latency in goatsCharacterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpesHIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts.Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection.An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection.BHV-1: new molecular approaches to control a common and widespread infectionImmunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2.Herpes simplex virus and the chemokines that mediate the inflammation.Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity.Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmissionRNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2.Recurrent vaginal shedding of herpes simplex type 2 virus in the mouse and effects of antiviral therapy.Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infectionCell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis.Prophylactic and therapeutic modulation of innate and adaptive immunity against mucosal infection of herpes simplex virusClearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanismsUse of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.In vivo requirement for Atg5 in antigen presentation by dendritic cells.Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safetyMechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulationRecruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue.Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virusA mucosal vaccination approach for herpes simplex virus type 2.Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpesImmunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 diseaseRapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functionsTopical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challengeInterleukin-21 receptor signalling is important for innate immune protection against HSV-2 infections.Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function.Innate and adaptive immune responses to herpes simplex virusEvasion of early antiviral responses by herpes simplex viruses.
P2860
Q26861168-4DECDE91-E1DF-476B-BE20-F82A97DC4A1AQ28083914-0D30AC31-B175-455B-9AE1-5FCA33850367Q28730610-B530D9D4-4B5F-4626-9637-3379573EF74EQ33248961-B419D5B4-95A8-4260-B7FF-22DF935A7E82Q33303686-361F6552-5526-4E42-8E7F-9E7045393BDAQ33625030-42108AC8-3862-45D8-951C-79AD11D90DB9Q33653142-79E7953D-1B6C-4A63-A1AC-6A84A5F13762Q33676923-D9E52EA8-4307-4A0F-81E6-0BCC15DFDFEEQ33785966-0A03D4C6-A2B7-4240-B7B4-1297D0C3020DQ33816722-3A65AE2C-A699-4E00-A561-5ED61EFBECA5Q33825406-953D0D29-B5BF-418D-9F05-38ECC62AC463Q33835204-36C8CFE7-5C8C-46B0-8335-BEFE3B5E9734Q33835246-FA0C5F2C-F56E-449F-8327-4CE0AFEAC950Q33835473-860DB82D-9BFC-4ED8-A8C7-26859F3B5C0AQ33836053-A5D41996-89FF-4A00-9BFE-FCE1E51D1891Q33843902-1F8126B0-5074-4FB9-8044-E5E1549A8369Q33850188-2F8BC85A-24A2-49DE-A988-981F0D41216DQ33883922-9D627D15-1E19-4F49-AF16-44BC3F9F6843Q33885018-DB0A5423-742A-47F0-AC87-10C3D320365BQ33980521-208D00BF-678D-4484-B782-E7A07F1EDA54Q34008683-627A61F3-2AA9-4DD1-803D-713D5B3B0394Q34105712-BE85FD42-8D01-46B0-9A4E-5124CCA174FDQ34142890-9F876A08-E0E9-42DF-BF5E-12A1D422FD3DQ34354995-542D0FE5-ED2A-4D26-869C-07C5C9F10DEEQ34376166-533422F2-EAED-47BB-BBA2-69B3CA0A5CA1Q34425552-F2C012B2-9E65-4E43-BB81-2A9A9F018700Q34471729-0AE1FED2-28FE-4004-8340-9B0717CF7AB8Q34471984-0BE0CFEC-CD79-4407-A195-6C2AF0D1BBBAQ34529742-BDF89F85-3907-4723-9C13-BE1E0E4625DAQ34529794-F48C3F04-17E1-459E-9E8E-A00E542D9FE8Q34558350-56EA1989-7742-49FD-84A0-3697ACF9148DQ34648207-D63F37CA-845D-4119-9E61-15FB5D4C95FCQ34742583-7CD08B96-C2B5-4410-A32D-4E58A64CF207Q34850941-602E3911-9A48-4864-A08F-7D401189F5E6Q34992660-E6C1F2DD-C9BD-4876-BAEA-B8EBEAFBA222Q35072560-43F58BB4-3C4C-46AE-A246-C4F51C56F7E9Q35182216-7AF7D6D1-E1D9-4FD2-962C-0EC7637205C3Q35209368-5B698665-68F5-455F-A7B3-D34A32F734C3Q35260078-02A5C15B-6C3E-421E-8B9C-894C7674953EQ35414669-7D8E817B-107B-438B-B700-F7AF96E7D6C7
P2860
Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Interferon-gamma enhances reso ...... n of the murine genital tract.
@en
Interferon-gamma enhances reso ...... n of the murine genital tract.
@nl
type
label
Interferon-gamma enhances reso ...... n of the murine genital tract.
@en
Interferon-gamma enhances reso ...... n of the murine genital tract.
@nl
prefLabel
Interferon-gamma enhances reso ...... n of the murine genital tract.
@en
Interferon-gamma enhances reso ...... n of the murine genital tract.
@nl
P356
P1433
P1476
Interferon-gamma enhances reso ...... n of the murine genital tract.
@en
P2093
Bernstein DI
Milligan GN
P304
P356
10.1006/VIRO.1997.8441
P407
P577
1997-03-01T00:00:00Z